These pathways stimulate the release of proinflammatory cytokines and chemokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which promote inflammation and endothelial dysfunction, recruit immune cells to the site of injury and exacerbate the inflammatory response. This evidence concerns the gene IL6 and endothelial dysfunction.